Matches in Wikidata for { <http://www.wikidata.org/entity/Q34547844> ?p ?o ?g. }
- Q34547844 description "2016 nî lūn-bûn" @default.
- Q34547844 description "2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած" @default.
- Q34547844 description "2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված" @default.
- Q34547844 description "2016年の論文" @default.
- Q34547844 description "2016年論文" @default.
- Q34547844 description "2016年論文" @default.
- Q34547844 description "2016年論文" @default.
- Q34547844 description "2016年論文" @default.
- Q34547844 description "2016年論文" @default.
- Q34547844 description "2016年论文" @default.
- Q34547844 description "2016年论文" @default.
- Q34547844 description "2016年论文" @default.
- Q34547844 description "2016年论文" @default.
- Q34547844 description "2016年论文" @default.
- Q34547844 description "2016年论文" @default.
- Q34547844 description "2016년 논문" @default.
- Q34547844 description "article científic" @default.
- Q34547844 description "article scientific" @default.
- Q34547844 description "article scientifique (publié 2016)" @default.
- Q34547844 description "articol științific" @default.
- Q34547844 description "articolo scientifico" @default.
- Q34547844 description "artigo científico (publicado na 2016)" @default.
- Q34547844 description "artigo científico (publicado na 2016)" @default.
- Q34547844 description "artigo científico" @default.
- Q34547844 description "artikull shkencor" @default.
- Q34547844 description "artikulong pang-agham" @default.
- Q34547844 description "artykuł naukowy" @default.
- Q34547844 description "artículo científico publicado en 2016" @default.
- Q34547844 description "artículu científicu espublizáu en 2016" @default.
- Q34547844 description "bilimsel makale" @default.
- Q34547844 description "bài báo khoa học" @default.
- Q34547844 description "mokslinis straipsnis" @default.
- Q34547844 description "naučni članak" @default.
- Q34547844 description "scienca artikolo" @default.
- Q34547844 description "scientific article" @default.
- Q34547844 description "teaduslik artikkel" @default.
- Q34547844 description "tieteellinen artikkeli" @default.
- Q34547844 description "tudományos cikk" @default.
- Q34547844 description "vedecký článok" @default.
- Q34547844 description "vetenskaplig artikel" @default.
- Q34547844 description "videnskabelig artikel (udgivet 2016)" @default.
- Q34547844 description "vitenskapelig artikkel" @default.
- Q34547844 description "vitskapeleg artikkel" @default.
- Q34547844 description "vědecký článek" @default.
- Q34547844 description "wetenschappelijk artikel" @default.
- Q34547844 description "wissenschaftlicher Artikel" @default.
- Q34547844 description "επιστημονικό άρθρο" @default.
- Q34547844 description "мақолаи илмӣ" @default.
- Q34547844 description "мақолаи илмӣ" @default.
- Q34547844 description "наукова стаття, опублікована в грудні 2016" @default.
- Q34547844 description "научна статия" @default.
- Q34547844 description "научная статья" @default.
- Q34547844 description "научни чланак" @default.
- Q34547844 description "научни чланак" @default.
- Q34547844 description "מאמר מדעי" @default.
- Q34547844 description "سائنسی مضمون" @default.
- Q34547844 description "مقالة علمية" @default.
- Q34547844 description "مقالهٔ علمی" @default.
- Q34547844 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34547844 description "บทความทางวิทยาศาสตร์" @default.
- Q34547844 description "სამეცნიერო სტატია" @default.
- Q34547844 name "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 name "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 name "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 type Item @default.
- Q34547844 label "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 label "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 label "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 prefLabel "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 prefLabel "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 prefLabel "Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab v" @default.
- Q34547844 P1433 Q34547844-46B16E6A-F952-47BD-87BF-7102E9770A98 @default.
- Q34547844 P1476 Q34547844-C69CA6B9-D9D9-4CDC-8586-6CBC6BFC1C99 @default.
- Q34547844 P2093 Q34547844-04ED62C1-485F-48A5-9FB3-B2716E740D40 @default.
- Q34547844 P2093 Q34547844-1EA7D2C3-D62B-45E9-9DD0-950F70CC8A31 @default.
- Q34547844 P2093 Q34547844-294F477F-03DB-41E4-926C-A4FD4E7A5C15 @default.
- Q34547844 P2093 Q34547844-47CA3D4D-4716-45C1-9338-5C34DB792CA1 @default.
- Q34547844 P2093 Q34547844-5196CEBD-1905-483A-ABF6-E083DDF1DD27 @default.
- Q34547844 P2093 Q34547844-5471F1F6-C563-40E4-AB21-C73B3AF06E8D @default.
- Q34547844 P2093 Q34547844-5626A1E8-FDCE-4972-83DA-F681FB07CB50 @default.
- Q34547844 P2093 Q34547844-59D18EE2-FB33-4DEE-BEEC-538296FB00B6 @default.
- Q34547844 P2093 Q34547844-67D14FF6-8909-42EC-90B1-3CF8B0D4FA33 @default.
- Q34547844 P2093 Q34547844-6B00F9AB-E17E-47F8-9EE7-AFCFD410F1B9 @default.
- Q34547844 P2093 Q34547844-76F2A1AF-C3B5-4A86-A3E7-857F179D1C4C @default.
- Q34547844 P2093 Q34547844-789B5AA8-054E-4E5F-8224-BE9BD3BE4D8D @default.
- Q34547844 P2093 Q34547844-7EE80BC3-2FAD-431F-B311-3528EC95AAD5 @default.
- Q34547844 P2093 Q34547844-8EF89EF9-2CC6-4D83-9D3A-18DC8272A79C @default.
- Q34547844 P2093 Q34547844-A7962C02-CF70-48C0-8C02-FAE4BF739DE7 @default.
- Q34547844 P2093 Q34547844-AACD9625-B1B4-47B4-B64A-1F07C1E46EEA @default.
- Q34547844 P2093 Q34547844-B3E3A832-4A80-4ECC-8267-BD0A1464EE2B @default.
- Q34547844 P2093 Q34547844-BEC4AF11-20C5-4671-81F2-BEC927400028 @default.
- Q34547844 P2093 Q34547844-C313E421-3885-4CB7-B5EE-4BEBCC213B25 @default.
- Q34547844 P2093 Q34547844-C4E40141-8945-4328-93B2-0A9E4E4E1036 @default.
- Q34547844 P2093 Q34547844-CF6FC844-FB7E-44C9-A0FC-4D4E712382B4 @default.
- Q34547844 P2093 Q34547844-E2032168-47ED-4AA0-84BD-FB4E20D1F5F6 @default.
- Q34547844 P2093 Q34547844-FC6E36A3-08F2-4FF2-8DC1-3B01BF6983D1 @default.
- Q34547844 P2860 Q34547844-04664E73-60C7-4DA3-A2C9-B509A706B287 @default.
- Q34547844 P2860 Q34547844-10C9B9EE-A1D9-4C5F-A311-226C357EC3E0 @default.
- Q34547844 P2860 Q34547844-1785CBA8-C658-425C-B6EF-87C584FC55BA @default.
- Q34547844 P2860 Q34547844-23440305-47A7-4F93-8859-115FA88ED7F6 @default.